Cardiovascular Risk Factors in Patients with Addison's Disease: A Comparative Study of South African and Swedish Patients

被引:22
作者
Ross, Ian Louis [1 ]
Bergthorsdottir, Ragnhildur [2 ]
Levitt, Naomi [1 ]
Dave, Joel Alex [1 ]
Schatz, Desmond [3 ]
Marais, David [4 ]
Johannsson, Gudmundur [2 ]
机构
[1] Univ Cape Town, Dept Med, Div Endocrinol, ZA-7925 Cape Town, South Africa
[2] Univ Gothenburg, Sahlgrenska Univ Hosp, Inst Med, Dept Endocrinol, Gothenburg, Sweden
[3] Univ Florida, Dept Paediat, Gainesville, FL USA
[4] Univ Cape Town, Natl Hlth Lab Serv, Div Chem Pathol, ZA-7925 Cape Town, South Africa
来源
PLOS ONE | 2014年 / 9卷 / 03期
关键词
LOW-DENSITY-LIPOPROTEIN; GLUCOCORTICOID REPLACEMENT THERAPY; CORONARY-HEART-DISEASE; ADRENAL INSUFFICIENCY; PLASMA; CHOLESTEROL; MORTALITY; SECRETION; HORMONES; TRENDS;
D O I
10.1371/journal.pone.0090768
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Patients with Addison's disease (AD) in Scandinavia have an increased risk for premature death due to cardiovascular disease (CVD). Serum lipids are important risk factors for CVD and vascular mortality. Replacement doses of hydrocortisone have historically been higher in Sweden than South Africa. The primary aim was to study the lipid profiles in a large group of patients with AD with the hypothesis that the lipid profile in patients in Sweden would be worse than in South Africa. Methods: In a cross-sectional study, 110 patients with AD (55 from South Africa, 55 from Sweden) matched for age, gender, ethnicity and BMI were studied. Anthropometric measures, blood pressure, lipids, highly sensitive C-reactive protein (hs-CRP) and adiponectin were studied. Results: All patients were Caucasian and the majority were women N = 36 (65.5%). Mean (standard deviation; SD) ages of the Swedish and South African patients were 52.9 (13.0) and 52.6 (14.4) years and BMI 25.3 (3.2) and 25.8 (4.1) kg/m(2), respectively. The mean total daily hydrocortisone dose was greater in the Swedish patients than the South African patients, [33.0 (8.1) versus 24.3 (8.0) mg; p<0.0001]. South African patients had higher median (interquartilerange; IQR) triglycerides (TG) [1.59 (1.1-2.46) versus 0.96 (0.74-1.6) mmol/l; p<0.001], total cholesterol (TC) [6.02(1.50) versus 5.13 (0.87) mmol/l; p<0.001], LDL-C [4.43 (1.44) versus 2.75 (0.80) mmol/l; p<0.001] and median hs-CRP [2.15 (0.93-5.45) versus 0.99 (0.57-2.10) mg/L; p<0.003] and lower HDL-C [0.80 (0.40) versus 1.86 (0.46) mmol/l; p<0.001] than the Swedish patients. Approximately 20% of the patients in both cohorts had hypertension and diabetes mellitus. Conclusions: South African patients with AD have worse lipid profiles and higher hs-CRP compared to their matched Swedish patients, despite lower doses of hydrocortisone. It is uncertain at this time whether these are due to genetic or environmental factors.
引用
收藏
页数:6
相关论文
共 39 条
[1]  
[Anonymous], GLOB HLTH ACTION
[2]   GLUCOCORTICOIDS AND TRIGLYCERIDE TRANSPORT - EFFECTS ON TRIGLYCERIDE SECRETION RATES, LIPOPROTEIN-LIPASE, AND PLASMA LIPOPROTEINS IN RAT [J].
BAGDADE, JD ;
YEE, E ;
ALBERS, J ;
PYKALISTO, OJ .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1976, 25 (05) :533-542
[3]   Increased death risk and altered cancer incidence pattern in patients with isolated or combined autoimmune primary adrenocortical insufficiency [J].
Bensing, Sophie ;
Brandt, Lena ;
Tabaroj, Farnoush ;
Sjoberg, Olof ;
Nilsson, Bo ;
Ekbom, Anders ;
Blomqvist, Paul ;
Kampe, Olle .
CLINICAL ENDOCRINOLOGY, 2008, 69 (05) :697-704
[4]   Premature mortality in patients with Addison's disease: A population-based study [J].
Bergthorsdottir, Ragnhildur ;
Leonsson-Zachrisson, Maria ;
Oden, Anders ;
Johannsson, Gudmundur .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (12) :4849-4853
[5]   Influence of hydrocortisone dosage scheme on health-related quality of life in patients with adrenal insufficiency [J].
Bleicken, Benjamin ;
Hahner, Stefanie ;
Loeffler, Melanie ;
Ventz, Manfred ;
Decker, Oliver ;
Allolio, Bruno ;
Quinkler, Marcus .
CLINICAL ENDOCRINOLOGY, 2010, 72 (03) :297-304
[6]   Effects of short-term glucocorticoids on cardiovascular biomarkers [J].
Brotman, DJ ;
Girod, JP ;
Garcia, MJ ;
Patel, JV ;
Gupta, M ;
Posch, A ;
Saunders, S ;
Lip, GYH ;
Worley, S ;
Reddy, S .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (06) :3202-3208
[7]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[8]   Correction of cortisol overreplacement ameliorates morbidities in patients with hypopituitarism: a pilot study [J].
Danilowicz, Karina ;
Bruno, Oscar Domingo ;
Manavela, Marcos ;
Gomez, Reynaldo Manuel ;
Barkan, Ariel .
PITUITARY, 2008, 11 (03) :279-285
[9]   Time trends in population cholesterol levels 1986-2004: influence of lipid-lowering drugs, obesity, smoking and educational level. The northern Sweden MONICA study [J].
Eliasson, M. ;
Janlert, U. ;
Jansson, J. -H. ;
Stegmayr, B. .
JOURNAL OF INTERNAL MEDICINE, 2006, 260 (06) :551-559
[10]   Normal overall mortality rate in Addison's disease, but young patients are at risk of premature death [J].
Erichsen, Martina M. ;
Lovas, Kristian ;
Fougner, Kristian J. ;
Svartberg, Johan ;
Hauge, Erik R. ;
Bollerslev, Jens ;
Berg, Jens P. ;
Mella, Bjarne ;
Husebye, Eystein S. .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2009, 160 (02) :233-237